CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
CNBX Pharmaceuticals EPS Diluted (Quarterly) : -0.0001 for May 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.0001 |
| February 28, 2026 | 0.00 |
| November 30, 2025 | -0.0002 |
| August 31, 2025 | -0.0003 |
| May 31, 2025 | -0.0014 |
| February 28, 2025 | -0.0022 |
| November 30, 2024 | -0.0011 |
| August 31, 2024 | -0.002 |
| May 31, 2024 | -0.0042 |
| February 29, 2024 | -0.0105 |
| November 30, 2023 | -0.0064 |
| August 31, 2023 | -0.0254 |
| May 31, 2023 | -0.0167 |
| February 28, 2023 | -1.337 |
| November 30, 2022 | -0.2843 |
| August 31, 2022 | -0.3873 |
| May 31, 2022 | -0.5502 |
| February 28, 2022 | -1.010 |
| November 30, 2021 | -1.097 |
| August 31, 2021 | -0.5652 |
| May 31, 2021 | -1.169 |
| February 28, 2021 | -0.474 |
| November 30, 2020 | -0.582 |
| August 31, 2020 | -0.6504 |
| May 31, 2020 | -0.6444 |
| Date | Value |
|---|---|
| February 29, 2020 | -0.7728 |
| November 30, 2019 | -4.616 |
| August 31, 2019 | -1.243 |
| May 31, 2019 | -0.486 |
| February 28, 2019 | 3.39 |
| November 30, 2018 | -0.6396 |
| August 31, 2018 | -0.7224 |
| May 31, 2018 | -0.8676 |
| February 28, 2018 | -1.68 |
| November 30, 2017 | -0.48 |
| August 31, 2017 | -1.108 |
| May 31, 2017 | -0.24 |
| February 28, 2017 | -0.48 |
| November 30, 2016 | -0.12 |
| August 31, 2016 | -0.0768 |
| May 31, 2016 | -0.03 |
| February 29, 2016 | -0.12 |
| November 30, 2015 | -0.12 |
| August 31, 2015 | -0.2424 |
| May 31, 2015 | -0.24 |
| February 28, 2015 | -0.0672 |
| November 30, 2014 | -0.1524 |
| May 31, 2014 | -0.0246 |
| February 28, 2014 | -0.0936 |
| November 30, 2013 | -0.2784 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.2295 |
| Arvinas, Inc. | 2.578 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
| Definium Therapeutics, Inc. | -1.436 |
| LeonaBio, Inc. | -0.8011 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1542M |
| Total Expenses (Quarterly) | 0.1542M |
| Enterprise Value | 1.305M |
| Earnings Yield | -600.0% |
| Normalized Earnings Yield | -600.00 |